Jasper Therapeutics (JSPR) Change in Taxes (2020)

Jasper Therapeutics (JSPR) posted quarterly Change in Taxes of -$7913.0 for Q4 2020, up 87.81% quarter-over-quarter from -$64940.0 in Q3 2020.

Jasper Therapeutics (JSPR) Change in Taxes (2020) Analysis & Trends

Jasper Therapeutics' Change in Taxes history runs 1 years deep, the most recent figure standing at -$7913.0 for Q4 2020.

In Q4 2020, Change in Taxes changed N/A year-over-year to -$7913.0; the TTM figure through Dec 2020 stood at -$16225.0 (changed N/A YoY), while the FY2020 annual figure was -$16225.0, down 200.0% from the prior year.
Change in Taxes for Q4 2020 stood at -$7913.0, up from -$64940.0 in the prior quarter.
The five-year high for Change in Taxes was $57823.0 in Q1 2020, with the low at -$64940.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Jasper Therapeutics	20.08 Mn	20.08 Mn	-	-

Download Data